[opensourcepharma] Recent OSP items
mattoddchem at gmail.com
Fri Nov 14 00:20:10 UTC 2014
A collection of recent items that may be of interest.
1. New GPCR consortium launched along the lines of the SGC:
(of interest to Peter Kolb and the GLISTEN network in the EU)
2. Discussion on "In the Pipeline" of the cancer crowdfunding campaign and
related issues such as patents:
3. Canadian government making major noises about the importance of open
4. Interesting-looking new call from the Gates Foundation
5. A number of review articles on drug discovery consortia were published
in the latest issue of Nat Rev Drug Disc
6. Time article on Margaret Chan's comments on Ebola and profit incentives
and an article on Ebola from Piero Olliaro and Els Torreele
7. Platform for crowd investments in health companies (nothing open, I
suspect, but...) - Bernard's an advisor
8) There was various coverage of a remark at a New York conference (
http://www.ifpmaassembly2014.org/About-this-event I believe) where the
incoming head of the International Federation of Pharmaceutical
Manufacturer's Association said "There is zero evidence that intellectual
property is a hindrance to access to medicines"
9) Substantial call for proposals by IMI based on ebola vaccines
and the IMI is considering a call for proposals in the area of "Knowledge
Repository to enable patient focused medicine development"
...which many of us would be interested in.
10) Interesting article on broad vs expert philanthropy
11) BBC article about challenges faced by the pharma industry
MATTHEW TODD | Associate Professor
School of Chemistry | Faculty of Science
THE UNIVERSITY OF SYDNEY
Rm 519, F11 | The University of Sydney | NSW | 2006
T +61 2 9351 2180 | F +61 2 9351 3329 | M +61 415 274104
E matthew.todd at sydney.edu.au | W
http://sydney.edu.au/science/chemistry/research/todd.html | W
This email plus any attachments to it are confidential. Any unauthorised
use is strictly prohibited. If you receive this email in error, please
delete it and any attachments.
-------------- next part --------------
An HTML attachment was scrubbed...
More information about the opensourcepharma